Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin

Double-walled nanoparticles (DWNPs), containing doxorubicin as a model drug, were produced using poly-(D,L-lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by the solvent evaporation technique. Double-walled microparticles containing doxorubicin were also produced to make possible the examina...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, M. Margarida, Peca, Inês N., Lopes, Telma, Gardner, Rui, Bicho, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512961/
https://www.ncbi.nlm.nih.gov/pubmed/34641046
http://dx.doi.org/10.3390/polym13193230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512961/
https://www.ncbi.nlm.nih.gov/pubmed/34641046
http://dx.doi.org/10.3390/polym13193230

Ejemplares similares